Abstract
ObjectivesTo assess the clinical utility of PET-CT in assessment of thoracic involvement in lymphoma patients prior to, during and after finishing treatment and comparing it to contrast enhanced CT (CECT). Patients and methodsPET-CT was performed for 30 patients with lymphoma. Thoracic nodal and extranodal involvement was assessed and compared to contrast enhanced CT. ResultsComparison of CECT and PET-CT in staging and assessment of treatment response reveals significant statistical difference (P = .0001 & .04 respectively). CECT shows sensitivity = 83.3% and specificity = 75% in evaluation of patients after finishing chemotherapy. ConclusionPET-CT plays an important role in staging, detection of response to treatment and restaging of lymphoma after finishing chemotherapy.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: The Egyptian Journal of Radiology and Nuclear Medicine
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
